Research Article

Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma

Table 1

The thirty-three EMT-related prognostic lncRNAs.

EMT-related lncRNAsTCGAICGC
HRHR.95LHR.95H valueHRHR.95LHR.95H value

AC017002.12.99851.03798.66291.48351.07442.0483
AC093850.21.29671.06051.58551.16531.01521.3376
LINC001521.95831.32432.89591.90651.27032.8615
LINC011161.74731.16702.61611.53781.18052.0033
MIR4435-1HG2.34641.41753.88392.33261.45463.7404
RP11-274H2.35.81721.478922.88211.35291.03521.7681
RP11-400 N13.31.66521.31552.10791.23041.07621.4068
RP11-417E7.11.50191.00332.24821.37281.16701.6149
RP11-554I8.21.65141.21142.25121.17281.04571.3153
UCA11.41711.22891.63411.34751.17981.5391
AC009506.10.23090.09020.59110.64980.45260.9330
AC096772.60.46480.27840.77620.58030.33730.9985
DANCR0.34180.21000.55620.65980.46650.9331
FLJ370350.01480.00070.31090.73400.58780.9165
GS1-358P8.40.37590.22460.62890.39350.23000.6734
HNF1A-AS10.57790.41570.80340.74020.59120.9267
LINC002610.69250.54610.87800.88590.80960.9693
LINC011280.28830.14610.56910.34580.17890.6681
PART10.04950.00260.94680.87450.76910.9944
PP70800.67830.49530.92880.75590.57290.9974
PRKAG2-AS10.66260.45260.97020.79830.66020.9652
RP11-16P6.10.08680.01840.40960.62570.39450.9926
RP11-226 L15.50.41600.20310.85210.57270.33370.9830
RP11-244O19.10.19630.07900.48740.72680.54350.9720
RP11-384 L8.10.53990.33820.86170.63990.50370.8129
RP11-700H6.10.06680.00870.51360.82890.72840.9433
RP1-193H18.20.33730.19300.58950.75160.60520.9334
RP11-968O1.50.50380.28150.90170.76500.59330.9863
RP5-1033H22.20.62040.39410.97660.80180.68840.9338
RP5-1085F17.30.37660.24020.59040.50240.28750.8779
RP5-894A10.20.58870.38420.90200.60400.42650.8554
SLC25A25-AS10.64390.46900.88390.74200.58670.9383
XXbac-B135H6.150.46220.28950.73770.69980.50270.9740

Color-shaded lncRNAs were risky lncRNAs, and others were protective lncRNAs.